ConductScience.org, home

Paper39701340

Impact of nanoparticle properties on immune cell interactions in the lymph node.

Farooq MA and 2 others. Acta Biomater, 2025. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. Impact of nanoparticle properties on immune cell interactions in the lymph node. Papers, record 39701340. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39701340

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Impact of nanoparticle properties on immune cell interactions in the lymph node.
PubMed
Journal
Acta Biomater
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
8.13, provisional
iCite
Revised in PubMed
2025-06-03
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Farooq MAMuhammad Asim
2Johnston APRAngus P R
3Trevaskis NLNatalie L

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Lymph NodesMajor topic
NanoparticlesMajor topic
Cell CommunicationMajor topic
Humans
Animals

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
42922362Physicochemical design principles for B cell targeted acetalated dextran microparticles in antigen-specific tolerance for multiple sclerosis.Biomater Sci2026https://conductscience.org/library/papers/42922362PubMed
42826091Engineered nanovaccines for prophylactic and therapeutic immunotherapy against cancer and infectious disease.Hum Vaccin Immunother2026https://conductscience.org/library/papers/42826091PubMed
42662463Increasing hydrophobicity in poly(amino acid) adjuvants elicits potent and durable anti-tumor immunity via coordinated cellular and humoral responses.Bioact Mater2027https://conductscience.org/library/papers/42662463PubMed
42540442Augmented therapeutic efficacy of Erianin through pH-responsive charge-reversal liposome integrated synergistic PTT and PDT in breast cancer.J Pharm Anal2026https://conductscience.org/library/papers/42540442PubMed
42513179Nanoparticle Engineering in Modern Vaccinology: From Delivery Platforms to Immune-Programming Architectures.Molecules2026https://conductscience.org/library/papers/42513179PubMed
42434845Nanoplatforms for Sentinel and Tumor-Draining Lymph Node Mapping: From Visualization to Pathway-Informed Staging.Adv Healthc Mater2026https://conductscience.org/library/papers/42434845PubMed
42272984Tissue-specific gene delivery approaches.Bioeng Transl Med2026https://conductscience.org/library/papers/42272984PubMed
42218454Rewiring the immune circuit: programming tumor-draining lymph node immunity with nanotechnology.J Nanobiotechnology2026https://conductscience.org/library/papers/42218454PubMed
42159453Senescent Cell Derived Artificial Vesicle-Based Senolytic Sonovaccine Platform with Augmented Lymph Node Delivery and Antigen Cross-Presentation Efficacy.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42159453PubMed
42120401Interventions and platforms that direct lymphangiogenesis to restore physiological homeostasis and enhance immunoregulation.NPJ Regen Med2026https://conductscience.org/library/papers/42120401PubMed
42005704Exosomes as Emerging Nanocarriers for Targeted Cancer Therapy.Int J Nanomedicine2026https://conductscience.org/library/papers/42005704PubMed
41847953Innovative γ-Oryzanol and KC2 Based Lipid Nanoparticles: OryKL Platform Provides Safe and Efficient In Vivo mRNA Delivery.Small2026https://conductscience.org/library/papers/41847953PubMed
41822464Microneedle-based transdermal delivery systems for metabolic bone diseases: advances, challenges, and future perspectives.Front Bioeng Biotechnol2026https://conductscience.org/library/papers/41822464PubMed
41648598Polymer-lipid hybrid nanoparticle enhances mRNA delivery and T cell-mediated immunity.bioRxiv2026https://conductscience.org/library/papers/41648598PubMed
41537174Regulatory T Cells and Nanomaterials: Dual Perspectives in Therapeutics and Immunomodulation.Small Sci2026https://conductscience.org/library/papers/41537174PubMed
41471111Oral Treatment of Obesity by GLP-1 and Its Analogs.Pharmaceutics2025https://conductscience.org/library/papers/41471111PubMed
41376820Engineering Nanoparticles to Modulate Extracellular Matrix and Immune Components of the Tumor Microenvironment in Cancer Immunotherapy.Biomater Res2025https://conductscience.org/library/papers/41376820PubMed
41357193Gut microbiota-derived metabolites in immunomodulation and gastrointestinal cancer immunotherapy.Front Immunol2025https://conductscience.org/library/papers/41357193PubMed
41235367Polyethyleneimine-modified Laminarin nanoparticles enhance antigen delivery to lymph nodes by inducing transient inflammatory responses at the injection site.Mater Today Bio2025https://conductscience.org/library/papers/41235367PubMed
40741064Evaluation of oral and injectable liposome-based vaccines with synthesized lipid for Japanese encephalitis virus in Sprague-Dawley rats.Clin Exp Vaccine Res2025https://conductscience.org/library/papers/40741064PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39701340

GET https://conductscience.org/api/papers/v1/39701340/cited_by?page=2